Prospective, comparative, pharmacodynamic study of two topical dosage regimens of a new finasteride formulation (0.25% o.d. and b.i.d.) and oral finasteride (1 mg o.d.) after 7 days multiple dose administration in male volunteers with androgenetic alopecia
Latest Information Update: 06 Oct 2022
At a glance
- Drugs Finasteride (Primary) ; Finasteride (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- Sponsors Polichem
- 07 Sep 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials
- 15 Aug 2012 New trial record